Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, sin...
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
About this item
Full title
Author / Creator
Publisher
Milan: Springer Milan
Journal title
Language
English
Formats
Publication information
Publisher
Milan: Springer Milan
Subjects
More information
Scope and Contents
Contents
Background
Clinical trials have shown that erenumab is effective and well-tolerated for the preventive treatment of chronic migraine. To extend the results from clinical trials, we assessed the real-world efficacy and safety of erenumab in patients with chronic migraine from the outpatient clinic at the Danish Headache Center.
Methods
A 52...
Alternative Titles
Full title
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bc1e00ecf6124af0b6ccf3440c24f7de
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bc1e00ecf6124af0b6ccf3440c24f7de
Other Identifiers
ISSN
1129-2369
E-ISSN
1129-2377
DOI
10.1186/s10194-022-01433-9
